Researchers of a new study say that two patients with leukemia continued to be in remission a decade after they were first infused with the experimental CAR T-cell therapy that turned their immune cells into cancer-killing cells. In 2010, Doug Olson and Bill Ludwig, participated in an experimental phase 1 clinical trial of the immunotherapy,…
First Patients Treated With Experimental Therapy Remained in Remission 10 Years Later: Study
February 5, 2022
admin
BrightCCP Viruschronic lymphocytic leukemiaDr. Carl H. Junegenetic engineeringHealth NewsMind & BodyNews & DiscoveriesPUBLIC HEALTH INFORMATIONUSUS News
0 Comment
First Leukemia Patients Treated With Experimental Therapy Remained in Remission 10 Years Later: Study
February 5, 2022
admin
BrightCCP Viruschronic lymphocytic leukemiaDr. Carl H. Junegenetic engineeringHealth NewsMind & BodyNews & DiscoveriesPUBLIC HEALTH INFORMATIONUSUS News
0 Comment
Researchers of a new study say that two patients with leukemia continued to be in remission a decade after they were first infused with the experimental CAR T-cell therapy that turned their immune cells into cancer-killing cells. In 2010, Doug Olson and Bill Ludwig, participated in an experimental phase 1 clinical trial of the immunotherapy,…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`